A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison

The summary for the A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison: Each year, approximately 6,500 persons with HIV living in prison facilities are released to the community, often lacking support for ongoing HIV care. There is a paucity of programming for this population that demonstrates effective retention in HIV care and sustained HIV viral suppression after release. The use of long-acting injectable antiretroviral therapy (LAI-ART) prior to and at the time of release from prison may improve adherence to HIV treatment, retention in care, and maintenance of viral load suppression among persons reentering the community. The primary purpose of this Notice of Funding Opportunity (NOFO) is to support the development and implementation of effective, sustainable, replicable LAI-ART programs for prison facilities and to understand the feasibility and acceptability of providing LAI-ART to persons with HIV living in prisons who are to be released to the community. Applied qualitative and quantitative research resulting from this funding is expected to strengthen adherence to ART.

Federal Grant Title:	A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-24-042
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 1st, 2024
Original Application Deadline:	March 1st, 2024
Posted Date:	December 1st, 2023
Creation Date:	December 1st, 2023
Archive Date:	March 31st, 2024
Total Program Funding:	$3,000,000
Maximum Federal Grant Award:	$375,000
Minimum Federal Grant Award:	$285,000
Expected Number of Awards:	2
Cost Sharing or Matching:	No
Last Updated:	December 1st, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: N/A
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
[email protected]
Similar Government Grants: • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...; • Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...; • PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed); • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Sci...